<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Li Y</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>To explore the plasma exosomal miRNA expression profiles in patients with abdominal obesity and type 2 diabetes mellitus (T2DM), identify differentially expressed exosomal m4RNAs, and evaluate the potential of selected exosomal miRNAs as biomarkers for abdominal obesity-related T2DM.&lt;h4>Methods&lt;/h4>In the screening phase, high-throughput sequencing was used to detect the plasma exosomal miRNA expression profiles of non-abdominal obese individuals with normal glucose metabolism (NAO/NG, N = 4), abdominal obese individuals with normal glucose metabolism (AO/NG, N = 4), and abdominal obese T2DM patients (AO/T2DM, N = 4). Five differentially expressed miRNAs were identified. In the independent validation phase, RT-qPCR was performed to validate the expression of these miRNAs in th</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>1656132</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12698432</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Plasma-derived exosomal miRNAs as potentially novel biomarkers for type 2 diabetes mellitus with abdominal obesity.</pubmed_title><pmcid>PMC12698432</pmcid><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Feng L</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Xing L</pubmed_authors><pubmed_authors>Zheng L</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Feng R</pubmed_authors><pubmed_authors>Jia J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma-derived exosomal miRNAs as potentially novel biomarkers for type 2 diabetes mellitus with abdominal obesity.</name><description>&lt;h4>Aims&lt;/h4>To explore the plasma exosomal miRNA expression profiles in patients with abdominal obesity and type 2 diabetes mellitus (T2DM), identify differentially expressed exosomal m4RNAs, and evaluate the potential of selected exosomal miRNAs as biomarkers for abdominal obesity-related T2DM.&lt;h4>Methods&lt;/h4>In the screening phase, high-throughput sequencing was used to detect the plasma exosomal miRNA expression profiles of non-abdominal obese individuals with normal glucose metabolism (NAO/NG, N = 4), abdominal obese individuals with normal glucose metabolism (AO/NG, N = 4), and abdominal obese T2DM patients (AO/T2DM, N = 4). Five differentially expressed miRNAs were identified. In the independent validation phase, RT-qPCR was performed to validate the expression of these miRNAs in th</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-06T02:52:17.557Z</modification><creation>2026-05-24T03:13:07.574Z</creation></dates><accession>S-EPMC12698432</accession><cross_references><pubmed>41393285</pubmed><doi>10.3389/fendo.2025.1656132</doi></cross_references></HashMap>